Comparison of Ribotest Legionella and Immunocatch Legionella for diagnosing Legionella pneumonia: A multicenter, prospective, observational study

Comparison of Ribotest Legionella and Immunocatch Legionella for diagnosing Legionella pneumonia: A multicenter, prospective, observational study - Comparison of Ribotest and Immunocatch for diagnosing Legionella pneumonia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043261

Enrollment

1000

Registered

2021-02-08

Start date

2021-02-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Legionella pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hospitalized community-acquired pneumonia patients or nursing and healthcare-associated pneumonia patients over 20 years of age who underwent the Legionella urinary antigen test

Exclusion criteria

Exclusion criteria: 1. Hospital-acquired pneumonia patients 2. Patients suspected to have aspiration pneumonia 3. Patients confirmed to have COVID-19

Design outcomes

Primary

Measure	Time frame
1. Diagnostic accuracies of Ribotest Legionella and Immunocatch Legionella for diagnosing Legionella pneumonia 2. Diagnostic accuracy of Ribotest Legionella for diagnosing Legionella pneumonia due to non-L. pneumophila serogroup 1	—

Secondary

Measure	Time frame
1. Clinical characteristics of Legionella pneumonia due to non-L. pneumophila serogroup 1 (comparison with Legionella pneumonia due to L. pneumophila serogroup 1) 2. Results of treatment for Legionella pneumonia 3. Validation of scoring systems for predicting Legionella pneumonia	—

Countries

Japan

Contacts

Public ContactAkihiro Ito

Ohara Healthcare Foundation, Kurashiki Central Hospital Department of Respiratory Medicine

ai12306@kchnet.or.jp086-422-0210

Outcome results